Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1

Infections with herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are a global health burden. Besides painful oral or genital lesions in otherwise healthy subjects, both viruses can cause devastating morbidity and mortality in immune-compromised and immune-immature individuals. The latter are p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccines (Basel)
Hauptverfasser: Silke Heilingloh, Christiane, Lull, Christopher, Kleiser, Elissa, Alt, Mira, Schipper, Leonie, Witzke, Oliver, Trilling, Mirko, Eis-Hübinger, Anna-Maria, Dittmer, Ulf, Krawczyk, Adalbert
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Brief Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7563860/
https://ncbi.nlm.nih.gov/pubmed/32867086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030478
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge